News

All news

2018-07-06

Precautionary recall of some Valsartan blood pressure and heart medicines

The Health Products Regulatory Authority (HPRA) have alerted Actavis Ireland Limited (part of the Accord Healthcare group) that there is a potential impurity issue with the supply of Valsartan active substance from a third-party facility.

We have taken immediate steps to recall the drug at a pharmacy level in accordance with HPRA guidelines. At present there is no evidence that this impurity has caused any harm to patients and the recall is a precautionary measure.
Patients prescribed Valsartan should speak to their local healthcare professional for further advice.

To view our letter to pharmacists please click here

All news